News from AIDS 2012

The 19th International AIDS Conference (AIDS 2012) took place in Washington, USA, 22nd-27th July 2012.

As the official online partner for scientific reporting, NAM published original news reporting and free email bulletins.

aidsmap news from AIDS 2012

How to tackle HIV stigma among health care workers

Stemming in part from negative associations with the virus itself, and in part from marginalisation of populations highly impacted by the virus, stigma and discrimination has long dissuaded

Published
02 August 2012
By
Mara Kardas-Nelson
Which interventions are best to reduce HIV infections among drug users?

HIV infections among drug users currently make up 30% of new infections globally. Their social marginalisation makes them an especially difficult group to target for public health and

Published
01 August 2012
By
Mara Kardas-Nelson
Changing the way HIV prevention is delivered – a roadmap

In the last few years there has been a wealth of dramatic data on the efficacy of new HIV prevention methods, including male circumcision, pre-exposure prophylaxis and

Published
01 August 2012
By
Roger Pebody
Poverty-targeted cash transfers are reducing some HIV risk behaviours

Cash transfers to orphans and vulnerable children in Kenya are associated with later onset of sexual activity and fewer sexual partners, but no increase in condom use among

Published
31 July 2012
By
Mara Kardas-Nelson
BCG vaccination causes immune activation of CD4 T-cells in infants

BCG vaccination, routinely given at birth to protect from tuberculosis (TB), causes an immune-activation of CD4 T cells, the HIV target cells, according to a South African

Published
31 July 2012
By
Lesley Odendal
Raltegravir 800mg twice daily appears a good alternative to efavirenz for HIV-TB treatment

Raltegravir seems to be a suitable alternative to efavirenz for HIV-TB co-infected patients while receiving TB treatment, according to 24-week results of the ANRS 12 180 REFLATE

Published
31 July 2012
By
Lesley Odendal
Female sex workers have 14 times the risk of having HIV as other women

Although researchers and public health organisations in most low and middle income countries have not collected any recent data on the prevalence of HIV in female sex

Published
31 July 2012
By
Roger Pebody
Once-daily elvitegravir works as well as raltegravir at 96 weeks

The investigational HIV integrase inhibitor elvitegravir taken once daily continued to perform as well as twice-daily raltegravir (Isentress) at 96 weeks for treatment-experienced people with extensive drug resistance,

Published
31 July 2012
By
Liz Highleyman
Cobicistat matches ritonavir as atazanavir booster

The new boosting agent cobicistat works as well as ritonavir (Norvir) as a pharmaco-enhancer or booster for the first-line protease inhibitor atazanavir (Reyataz) at 48 weeks, according to

Published
30 July 2012
By
Liz Highleyman
Black gay men in the UK almost twice as likely to have HIV as white men, meta-analysis shows

A new analysis of existing studies on the sexual health of black gay men in the UK has found that despite having similar sexual risk behaviours to

Published
30 July 2012
By
Roger Pebody

Sign up today

Sign up for our regular email bulletins:

Find out more and sign up to the full range of aidsmap email bulletins >

AIDS 2012 tweets

Click here for more >

More coverage of the conference

Two other official partners of the conference are providing coverage and analysis online.

Clinical Care Options (CCO) provide audio highlights, capsule summaries and downloadable slidesets, while the Kaiser Family Foundation provide webcasting from conference sessions.

NAM is partnering with UNICEF to deliver the AIDS 2012 bulletins, which have also been made possible thanks to support from Bristol-Myers Squibb and Vestergaard Frandsen. NAM’s wider conference news reporting services have been supported by Abbott, Boehringer Ingelheim, Janssen, Roche and ViiV Healthcare.